The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
General population normative data for the EORTC QLQ-C30 health-related quality of life questionnaire based on 15,386 persons across 13 European countries, Canada and the Unites States
Open accessAbstract
OBJECTIVE: The European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 health-related quality of life questionnaire is one of the most widely used cancer-specific health-related quality of life questionnaires worldwide. General population norm data can facilitate the interpretation of QLQ-C30 data obtained from cancer patients. This study aimed at systematically collecting norm data from the general population to develop European QLQ-C30 norm scores and to generate comparable norm data for individual countries in Europe and North America. METHODS: We collected QLQ-C30 data from the general population across 11 European Union (EU) countries, Russia, Turkey, Canada and United States (n ≥ 1000/country). Representative samples were stratified by sex and age groups (18-39, 40-49, 50-59, 60-69 and ≥ 70 years). After applying weights based on the United Nations population distribution statistics, we calculated QLQ-C30 domain scores to generate a 'European QLQ-C30 Norm' based on the EU countries. Further, we calculated QLQ-C30 norm scores for all 15 individual countries. RESULTS: A total of 15,386 respondents completed the online survey. For the EU sample, most QLQ-C30 domains showed differences by sex/age, with men scoring somewhat better health than women, while age effects varied across domains. Substantially larger differences were seen in inter-country comparisons, with Austrian and Dutch respondents reporting consistently better health compared with British and Polish respondents. CONCLUSIONS: This study is the first to systematically collect EORTC QLQ-C30 general population norm data across Europe and North America applying a consistent data collection method across 15 countries. These new norm data facilitate valid intra-country as well as inter-country comparisons and QLQ-C30 score interpretation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., Filiberti, A., Flechtner, H., Fleishman, S. B., Haes, J. C. J. M. D., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.5.365 · Cited by 16,005
Self-citationWorld Population Prospects The 2006 Revision
Zlotnik, H. (2007) · United Nations eBooks · Cited by 7,898
Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment
Breivik, H., Collett, B., Ventafridda, V., Cohen, R., & Gallacher, D. (2006) · European Journal of Pain · doi:10.1016/j.ejpain.2005.06.009 · Cited by 5,486
The size and burden of mental disorders and other disorders of the brain in Europe 2010
Wittchen, H. U., Jacobi, F., Rehm, J., Gustavsson, A., Svensson, M., Jönsson, B., Olesen, J., Allgulander, C., Alonso, J., Faravelli, C., et al. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.07.018 · Cited by 3,754
Cella, D., Yount, S., Rothrock, N., Gershon, R., Cook, K., Reeve, B., Ader, D., Fries, J. F., Bruce, B., & Rose, M. (2007) · Medical Care · doi:10.1097/01.mlr.0000258615.42478.55 · Cited by 3,118
Self-citationInterpreting the significance of changes in health-related quality-of-life scores.
Osoba, D., Rodrigues, G., Myles, J., Zee, B., & Pater, J. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.1.139 · Cited by 2,961
Fayers, P. M., Aaronson, N. K., Bjordal, K., Groenvold, M., Curran, D., & Bottomley, A. (2001) · Research at the University of Copenhagen (University of Copenhagen) · Cited by 2,521
Self-citationQuality of life research within the EORTC—the EORTC QLQ-C30
Fayers, P., & Bottomley, A. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00448-8 · Cited by 924
Self-citationStandardizing Patient Outcomes Measurement
Porter, M. E., Larsson, S., & Lee, T. H. (2016) · New England Journal of Medicine · doi:10.1056/nejmp1511701 · Cited by 626 · cited 1×
“One possible approach d as taken by the International Consortium for Health Outcomes Measurement (ICHOM) d is to define standard sets of existing PRO instruments to enable comparison of outcomes across health-care providers and geographies [6].”
BackgroundReference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population
Schwarz, R., & Hinz, A. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00447-0 · Cited by 503
Representativeness of the Patient-Reported Outcomes Measurement Information System Internet panel
Liu, H., Cella, D., Gershon, R., Shen, J., Morales, L. S., Riley, W., & Hays, R. D. (2010) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.11.021 · Cited by 446
Helena Michelson, C. B. (2000) · Acta Oncologica · doi:10.1080/028418600750013384 · Cited by 379
Hjermstad, M. J., Fayers, P. M., Bjordal, K., & Kaasa, S. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.3.1188 · Cited by 368
Self-citationHjermstad, M. J., Fayers, P. M., Bjordal, K., & Kaasa, S. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00136-1 · Cited by 282
Self-citationRevicki, D. A., & Cella, D. F. (1997) · Quality of Life Research · doi:10.1023/a:1018420418455 · Cited by 268
Overweight and obesity in 16 European countries
Gallus, S., Lugo, A., Murisic, B., Bosetti, C., Boffetta, P., & La Vecchia, C. (2015) · European Journal of Nutrition · doi:10.1007/s00394-014-0746-4 · Cited by 260
Ong, W. L., Schouwenburg, M. G., van Bommel, A. C. M., Stowell, C., Allison, K. H., Benn, K. E., Browne, J. P., Cooter, R. D., Delaney, G. P., Duhoux, F. P., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2016.4851 · Cited by 241
Hinz, A., Singer, S., & Brähler, E. (2014) · Acta Oncologica · doi:10.3109/0284186x.2013.879998 · Cited by 225
Bergqvist, K., Yngwe, M. Å., & Lundberg, O. (2013) · BMC Public Health · doi:10.1186/1471-2458-13-1234 · Cited by 208
Normative data for the EORTC QLQ-C30 and EORTC-sexuality items in the general Dutch population
van de Poll-Franse, L. V., Mols, F., Gundy, C. M., Creutzberg, C. L., Nout, R. A., Verdonck-de Leeuw, I. M., Taphoorn, M. J., & Aaronson, N. K. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2010.11.004 · Cited by 208
Self-citationUse of patient-reported outcomes in clinical practice
Snyder, C. F., & Aaronson, N. K. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61400-8 · Cited by 199
Self-citationIncorporating the patient experience into regulatory decision making in the USA, Europe, and Canada
Kluetz, P. G., O'Connor, D. J., & Soltys, K. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30097-4 · Cited by 198
Derogar, M., van der Schaaf, M., & Lagergren, P. (2011) · Acta Oncologica · doi:10.3109/0284186x.2011.614636 · Cited by 150
Zerillo, J. A., Schouwenburg, M. G., van Bommel, A. C. M., Stowell, C. J., Lippa, J., Bauer, D., Berger, A. M., Boland, G., Borràs, J. M., Buss, M. K., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2017.0417 · Cited by 142
Quality of life of Danish women: Population-based norms for the EORTC QLQ-C30
Klee, M., Groenvold, M., & Machin, D. (1997) · Quality of Life Research · doi:10.1023/a:1026461310761 · Cited by 137
Self-citationHealth-Related Quality of Life Measurement in Randomized Clinical Trials in Surgical Oncology
Blazeby, J. M., AVERY, K. N. L., Sprangers, M. A. G., Pikhart, H., Fayers, P. M., & Donovan, J. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.2951 · Cited by 129
Self-citationWhat Do We Rate When We Rate Our Health? Decomposing Age-related Contributions to Self-rated Health
Idler, E. L., & Cartwright, K. (2018) · Journal of Health and Social Behavior · doi:10.1177/0022146517750137 · Cited by 118
The EORTC CAT Core—The computer adaptive version of the EORTC QLQ-C30 questionnaire
Petersen, M. A., Aaronson, N. K., Arrarás, J. I., Chie, W., Conroy, T., Costantini, A., Dirven, L., Fayers, P. M., Gamper, E., Giesinger, J. M., et al. (2018) · European Journal of Cancer · doi:10.1016/j.ejca.2018.04.016 · Cited by 110
Self-citationNormative Data of the EORTC QLQ-C30 For the German Population: A Population-Based Survey
Waldmann, A., Schubert, D., & Katalinic, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074149 · Cited by 109
Self-citationJuul, T., Petersen, M. A., Holzner, B., Laurberg, S., Christensen, P., & Grøenvold, M. (2014) · Quality of Life Research · doi:10.1007/s11136-014-0675-y · Cited by 94
Self-citationComparing translations of the EORTC QLQ-C30 using differential item functioning analyses
on behalf of the EORTC and the Quality of Life Cross-Cultural Meta-Analysis Group, SCOTT, N. W., Fayers, P. M., Bottomley, A., Aaronson, N. K., de Graeff, A., Groenvold, M., Koller, M. T., Petersen, M. A., & Sprangers, M. A. G. (2006) · Quality of Life Research · doi:10.1007/s11136-006-0040-x · Cited by 75
Self-citationLiegl, G., Petersen, M. A., Grøenvold, M., Aaronson, N. K., Costantini, A., Fayers, P. M., Holzner, B., Johnson, C. D., Kemmler, G., Tomaszewski, K. A., et al. (2018) · European Journal of Cancer · doi:10.1016/j.ejca.2018.11.023 · Cited by 72
Self-citationMols, F., Husson, O., Oudejans, M., Vlooswijk, C. C. P., Horevoorts, N. J. E., & van de Poll-Franse, L. V. (2018) · Acta Oncologica · doi:10.1080/0284186x.2018.1481293 · Cited by 54
Velenik, V., Secerov-Ermenc, A., But-Hadžić, J., & Zadnik, V. (2017) · Radiology and Oncology · doi:10.1515/raon-2017-0021 · Cited by 42
Fischer, F. H., & Rose, M. (2016) · BMC Medical Research Methodology · doi:10.1186/s12874-016-0241-0 · Cited by 29
Self-citationBasch, E., & Dueck, A. C. (2016) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2016.1193148 · Cited by 24
Shields, A. L., Hao, Y., Krohe, M., Yaworsky, A., Mazar, I., Foley, C., Mehmed, F., & GLOBE, D. R. (2016) · Europe PMC (PubMed Central) · Cited by 13
Cited by
Daratumumab or active monitoring for high-risk smoldering multiple myeloma
Dimopoulos, M. A., Voorhees, P. M., Schjesvold, F., Cohen, Y. C., Hungria, V., Sandhu, I., Lindsay, J., Baker, R. I., Suzuki, K., Kosugi, H., et al. (2025) · New England Journal of Medicine · doi:10.1056/nejmoa2409029 · Cited by 121
Jeppesen, S. S., Bentsen, K. K., Jørgensen, T. L., Holm, H. S., Holst-Christensen, L., Tarpgaard, L. S., Dahlrot, R. H., & Eckhoff, L. (2021) · Acta Oncologica · doi:10.1080/0284186x.2020.1830169 · Cited by 61
Cancer Care During COVID-19 Era: The Quality of Life of Patients With Thyroid Malignancies
Falcone, R., Grani, G., Ramundo, V., Melcarne, R., Giacomelli, L., Filetti, S., & Durante, C. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01128 · Cited by 42
“The results were compared with published normative data (21).”
ResultKoinig, K. A., Arnold, C., Lehmann, J., Giesinger, J., Köck, S., Willenbacher, W., Weger, R., Holzner, B., Ganswindt, U., Wolf, D., et al. (2021) · Cancer Medicine · doi:10.1002/cam4.3950 · Cited by 34
Self-citationDelforge, M., Patel, K., Eliason, L., Dhanda, D., Shi, L., Guo, S., Marshall, T. S., Arnulf, B., Cavo, M., Nooka, A., et al. (2024) · The Lancet Haematology · doi:10.1016/s2352-3026(24)00005-x · Cited by 31
Metadata
- Authors
- Nolte, S., Liegl, G., Petersen, M. A., Aaronson, N. K., Costantini, A., Fayers, P. M., Groenvold, M., Holzner, B., Johnson, C. D., Kemmler, G., Tomaszewski, K. A., Waldmann, A., Young, T. E., & Rose, M.
- Venue
- European Journal of Cancer
- Publisher
- Elsevier BV
- Published
- 2019-01
- Volume
- 107
- Pages
- 153-163
- ISSN
- 0959-8049 (ISSN-L)
- OpenAlex
- W2906639914
- Cited by
- 462
- References
- 37
- FWCI
- 13.57
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- Funders
- European Organisation for Research and Treatment of Cancer (001 2015)
- Austrian Science Fund (FWF #P26930)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.